Assessment the therapeutic potential and safety profile of traditional antiobesity herbal drugs in Saudi Arabia

Pharmacology, Toxicology and Pharmaceutical Science

1. Acute Disease 8%
2. Adverse Event 16%
3. Alanine Aminotransferase 16%
4. Antiobesity Drugs 25%
5. Aspartate Aminotransferase 8%
6. Bioavailability 8%
7. Calorimetry 8%
8. Cardiovascular Disease 8%
9. Carvedilol 8%
10. Chronic Disease 16%
11. Chronic Toxicity Study 8%
12. Clinical Trial 8%
13. Creatinine 8%
14. Diet Induced Obesity 8%
15. Dietary Supplement 8%
16. Diseases 91%
17. Experimental Animal 8%
18. Flavonoid 16%
19. Genetic Disorder 8%
20. Glucose 8%
21. Herbaceous Agent 100%
22. Ischemic Heart Disease 8%
23. Kidney Disease 8%
24. Leptin 16%
25. Lipoprotein 25%
26. Lung Cancer 8%
27. Medicinal Plant 16%
28. Morbid Obesity 8%
29. Natural Product 16%
30. Nitrogen 8%
31. Nonalcoholic Fatty Liver 8%
32. Pathophysiology 8%
33. Pharmacodynamics 8%
34. Pharmacotherapy 16%
35. Prematurity 8%
36. Prevalence 8%
37. Rat 8%
38. Respiratory Tract Disease 8%
39. Salicylate Sodium 33%
40. Side Effect 41%
41. Structure Activity Relationship 8%
42. Triacylglycerol 8%
43. Ureaplasma 8%